Business Context and Reporting Period
This Form 8-K Current Report is filed by Global Medical REIT Inc. (not Chiron Real Estate Inc.) on February 2, 2017, regarding events occurring on January 30, 2017. The filing details the entry into a material definitive agreement to acquire a portfolio of three medical properties in Oklahoma City, Oklahoma.
Key Financial Metrics and Transaction Details
- Aggregate Purchase Price: $49,500,000
- Properties Acquired:
- OCOM Hospital (69,811 sq. ft.)
- OCOM Physical Therapy Center (20,434 sq. ft.)
- OCOM North Ambulatory Surgical Center (10,086 sq. ft.)
- Lease Structure (OCOM South):
- Existing tenant lease (OCOM South Lease) expires September 1, 2033, with three 5-year renewal options.
- Guarantees: 25% by United Surgical Partners International, Inc. (USPI) and 25% by INTEGRIS Health, Inc.
- New Master Lease (5-year term) with initial rent of $3,138,912 and 1.4% annual escalations.
- Post-Master Lease direct rent: $3,365,188 annually with 2.0% escalations.
- Lease Structure (OCOM North):
- Existing lease expires July 31, 2022, with two 5-year renewal options.
- Current annual rent: $383,161.
- Escalations: CPI-based (min 0%, max 4.0% annually; max 2.5% compounded annually).
- Liquidity/Debt: The filing does not provide specific data on the company's overall debt, cash flow, or liquidity position. It notes that the seller (Cruse-Two) will provide a standby letter of credit for the Master Lease additional rent, less $220,782 held in escrow.
Material Changes and Conditions
The primary material change is the execution of the Purchase Agreement to acquire the Oklahoma City portfolio. The transaction is subject to customary closing conditions. The Company retains the right to terminate the agreement without penalty on or before March 10, 2017, if due diligence results are unsatisfactory. In the event of termination, the earnest money deposit becomes non-refundable.
Outlook, Risks, and Management Commentary
Management believes the completion of the acquisition is probable but explicitly states there is no assurance the deal will close. The filing includes standard forward-looking statements regarding the expected lease terms and transaction completion, noting these are subject to risks and uncertainties beyond the Company's control. The Company disclaims any obligation to update these statements unless legally required.
Investor Verification Checklist
- Verify the final closing date and confirmation that the transaction was not terminated by the March 10, 2017 deadline.
- Confirm the funding source for the $49.5 million purchase price (e.g., cash on hand, debt financing, or equity issuance).
- Review the full text of the Purchase Agreement (Exhibit 10.1) and Lease Agreements (Exhibits 10.2, 10.3, 10.4) for specific covenants and termination clauses.
- Assess the creditworthiness of the guarantors (USPI and INTEGRIS Health) and the Master Tenant (Cruse-Two).
- Check subsequent filings for any updates on the "five executed purchase contracts" mentioned in the press release (Exhibit 99.1) referenced in Item 7.01.